News

1. Ypsomed Opens Production Site In China 8/12/2026
2. Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity 8/12/2026
3. Ypsomed Expands Offering For Clinical Studies 8/12/2026
4. Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop 8/12/2026
5. Ypsomed Receives FDA Clearance For SmartPilot 8/12/2026
6. Kindeva Appoints Brok Weichbrodt As Chief Transformation Officer To Accelerate Growth Strategy And Commercial Excellence 7/14/2026
7. Four Myths About Embedded CMOs, Busted 6/17/2026

   If you’re looking for a contract manufacturer to bring your therapy to market, you’re far from alone. Demand for manufacturing services is shaping the pharma Contract Manufacturing Industry, with analysts predicting a growth rate of nearly 7% per year until 2028.

8. Avoiding Recalls: How To Ensure Sterility In Ophthalmic Products 6/17/2026

   In the wake of several high-profile eye drop recalls, we look at the challenges of achieving sterility in ophthalmic products, the consequences of failing to do so, and how AbbVie Contract Manufacturing ensures product sterility and safety.

9. Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery 5/12/2026

   Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance‑enhancing company, today announced that it has signed an exclusivity agreement with a U.S. biopharmaceutical company (Nasdaq listed, Mcap USD 1Bn+) for the application of Nanoform’s proprietary biologics nanoparticle technology to support the development of differentiated subcutaneous biologic medicines.

10. Kindeva® Commemorates 70 Years Of The pMDI As Inventors Are Inducted Into The 'National Inventors Hall Of Fame' 3/26/2026